Apex Biotechnology Corp. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 576.388 million compared to TWD 511.930 million a year ago. Operating income was TWD 62.270 million compared to TWD 15.087 million a year ago. Net income was TWD 34.161 million compared to TWD 11.968 million a year ago. Basic earnings per share from continuing operations was TWD 0.34 compared to TWD 0.12 a year ago. Diluted earnings per share from continuing operations was TWD 0.31 compared to TWD 0.11 a year ago.